Diazoxide Choline in Hypertriglyceridemia
Public ClinicalTrials.gov record NCT00696475. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Diazoxide Choline in Non-Diabetic Hypertriglyceridemic Subjects
Study identification
- NCT ID
- NCT00696475
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Essentialis, Inc.
- Industry
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- Diazoxide choline Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2008
- Primary completion
- Dec 31, 2008
- Completion
- Feb 28, 2009
- Last update posted
- Nov 7, 2010
2008 – 2009
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Research Institute | Los Angeles | California | 90057 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Allied Research International/Cetero Research | Miami Gardens | Florida | 33169 | — |
| Meridien Research | Tampa | Florida | 33606 | — |
| Midwest Institute for Clinical Research | Indianapolis | Indiana | 46260 | — |
| L-MARC Research Center | Louisville | Kentucky | 40213 | — |
| St. Luke's Lipid and Diabetes Research Center | Kansas City | Missouri | 64111 | — |
| Piedmont Medical Research Associates | Winston-Salem | North Carolina | 27103 | — |
| Metabolic and Atherosclerosis Research Center (MARC) | Cincinnati | Ohio | 45212 | — |
| Sterling Research Group, Ltd | Cincinnati | Ohio | 45219 | — |
| Frederick C. Smith Clinic | Marion | Ohio | 43302 | — |
| TriCities Medical Research | Bristol | Tennessee | 37620 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00696475, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2010 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00696475 live on ClinicalTrials.gov.